These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 11470964)

  • 21. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin.
    Im E; Yoo L; Hyun M; Shin WH; Chung KC
    Open Biol; 2016 Aug; 6(8):. PubMed ID: 27534820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinson's disease with Lewy bodies associated with a heterozygous PARKIN dosage mutation.
    Sharp ME; Marder KS; Côté L; Clark LN; Nichols WC; Vonsattel JP; Alcalay RN
    Mov Disord; 2014 Apr; 29(4):566-8. PubMed ID: 24375549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the parkin deletion in sporadic and familial Parkinson's disease. Short communication.
    Krüger R; Vieira-Säcker AM; Kuhn W; Müller T; Woitalla D; Schöls L; Przuntek H; Epplen JT; Riess O
    J Neural Transm (Vienna); 1999; 106(2):159-63. PubMed ID: 10226936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of oxidative stress on parkin and other E3 ligases.
    LaVoie MJ; Cortese GP; Ostaszewski BL; Schlossmacher MG
    J Neurochem; 2007 Dec; 103(6):2354-68. PubMed ID: 17883392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease.
    Oliveira SA; Scott WK; Martin ER; Nance MA; Watts RL; Hubble JP; Koller WC; Pahwa R; Stern MB; Hiner BC; Ondo WG; Allen FH; Scott BL; Goetz CG; Small GW; Mastaglia F; Stajich JM; Zhang F; Booze MW; Winn MP; Middleton LT; Haines JL; Pericak-Vance MA; Vance JM
    Ann Neurol; 2003 May; 53(5):624-9. PubMed ID: 12730996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heredity in Parkinson's disease: new findings.
    Lev N; Melamed E
    Isr Med Assoc J; 2001 Jun; 3(6):435-8. PubMed ID: 11433638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The p38 subunit of the aminoacyl-tRNA synthetase complex is a Parkin substrate: linking protein biosynthesis and neurodegeneration.
    Corti O; Hampe C; Koutnikova H; Darios F; Jacquier S; Prigent A; Robinson JC; Pradier L; Ruberg M; Mirande M; Hirsch E; Rooney T; Fournier A; Brice A
    Hum Mol Genet; 2003 Jun; 12(12):1427-37. PubMed ID: 12783850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lewy body Parkinson's disease in a large pedigree with 77 Parkin mutation carriers.
    Pramstaller PP; Schlossmacher MG; Jacques TS; Scaravilli F; Eskelson C; Pepivani I; Hedrich K; Adel S; Gonzales-McNeal M; Hilker R; Kramer PL; Klein C
    Ann Neurol; 2005 Sep; 58(3):411-22. PubMed ID: 16130111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkin and endoplasmic reticulum stress.
    Takahashi R; Imai Y; Hattori N; Mizuno Y
    Ann N Y Acad Sci; 2003 Jun; 991():101-6. PubMed ID: 12846978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism.
    Kitada T; Asakawa S; Hattori N; Matsumine H; Yamamura Y; Minoshima S; Yokochi M; Mizuno Y; Shimizu N
    Nature; 1998 Apr; 392(6676):605-8. PubMed ID: 9560156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease.
    Biswas S; Roy R; Biswas R; Bagchi A
    Gene; 2020 Feb; 726():144186. PubMed ID: 31647998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional association of the parkin gene promoter with idiopathic Parkinson's disease.
    West AB; Maraganore D; Crook J; Lesnick T; Lockhart PJ; Wilkes KM; Kapatos G; Hardy JA; Farrer MJ
    Hum Mol Genet; 2002 Oct; 11(22):2787-92. PubMed ID: 12374768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenetic mechanisms of parkin in Parkinson's disease.
    Hattori N; Mizuno Y
    Lancet; 2004 Aug 21-27; 364(9435):722-4. PubMed ID: 15325839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Programmed cell death-2 isoform1 is ubiquitinated by parkin and increased in the substantia nigra of patients with autosomal recessive Parkinson's disease.
    Fukae J; Sato S; Shiba K; Sato K; Mori H; Sharp PA; Mizuno Y; Hattori N
    FEBS Lett; 2009 Feb; 583(3):521-5. PubMed ID: 19146857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation mechanisms of the E3 ubiquitin ligase parkin.
    Panicker N; Dawson VL; Dawson TM
    Biochem J; 2017 Aug; 474(18):3075-3086. PubMed ID: 28860335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The genetics of Parkinson syndrome].
    Klein C
    Praxis (Bern 1994); 2001 Jun; 90(23):1015-23. PubMed ID: 11447721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetics of Parkinson's disease.
    Gasser T
    J Neurol; 2001 Oct; 248(10):833-40. PubMed ID: 11697518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PARKIN as a pathogenic gene for autosomal recessive juvenile parkinsonism.
    Shimizu N; Asakawa S; Minoshima S; Kitada T; Hattori N; Matsumine H; Yokochi M; Yamamura Y; Mizuno Y
    J Neural Transm Suppl; 2000; (58):19-30. PubMed ID: 11128608
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkin-associated Parkinson's disease.
    von Coelln R; Dawson VL; Dawson TM
    Cell Tissue Res; 2004 Oct; 318(1):175-84. PubMed ID: 15503153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
    Sriram SR; Li X; Ko HS; Chung KK; Wong E; Lim KL; Dawson VL; Dawson TM
    Hum Mol Genet; 2005 Sep; 14(17):2571-86. PubMed ID: 16049031
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.